ClinicalTrials.Veeva

Menu

Cardiac Arrest Post-Discharge ECG Monitoring (CArPEM)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Unknown

Conditions

Heart Arrest
Electrocardiography
Arrhythmias, Cardiac

Treatments

Device: ECG patch (Philips ePatch® 2.0)

Study type

Observational

Funder types

Other

Identifiers

NCT05337371
Cardiac Arrest ECG

Details and patient eligibility

About

The primary aim is to conduct a prospective observational cohort study to analyze the incidence of serious arrhythmic events that occur within 14 days after hospital discharge in patients who had been hospitalized for cardiac arrest caused by acute myocardial infarction. Cardiac arrythmias following hospital dischagre will be detected with Philips ePatch® 2.0 for 14 days.

Full description

Approximately 60,000 patients suffer from out-of-hospital cardiac arrest in Germany every year. Areas of myocardial ischemia may induce cardiac arrythmias, such as atrial fibrillation, ventricular tachycardia or ventricular fibrillation, which are known arrhythmic complications following cardiac arrest. Additionally, an imbalance in electrolytes as well as an increased use of inotropic or vasoactive medication as part of post-resuscitation care in the intensive care unit (ICU) may further increase the risk of cardiac arrythmias. 80% of cardiac arrythmias occur within 24 hours after cardiac arrest in the ICU. Patients with cardiac arrythmias following cardiac arrest have an increased mortality risk. Therefore, patients with cardiac arrest are monitored closely with telemetric monitors in the hospital, revascularized early and treated with beta-blockers, statins and renin-angiotensin-aldosterone antagonists to enhance myocardial remodeling and to decrease the rate of cardiac arrythmias. As soon as the patients are discharged from the hospital, no telemetric ECG monitoring can be provided. Therefore, the incidence of early cardiac arrythmias, which occur within 14 days after hospital discharge after treatment for cardiac arrest, remains unclear.

We plan to include 100 adult patients (≥18 years and ≤80 years) who survived cardiac arrest caused by acute myocardial infarction within the past 10 days. Patients with a left-ventricular ejection fraction between 36 to 50% and with sinus rhythm at the time of hospital discharge will be enrolled in this study. Patients who are suitable for implantable cardioverter-defibrillators (ICD) or pacemakers, with known paroxysmal or persistent atrial fibrillation, known inability to comply with follow-up or known pregnancy will not be enrolled.

Primary aim: The primary aim is to conduct a prospective observational cohort study to analyze the incidence of serious arrhythmic events that occur within 14 days after hospital discharge in patients who had been hospitalized for cardiac arrest caused by acute myocardial infarction. Cardiac arrythmias following hospital dischagre will be detected with Philips ePatch® 2.0 for 14 days.

Secondary aims: The secondary aim is to analzye the incidence of sinus arrest, atrial fibrillation, higher degree AV-block, ventricular tachycardia or fibrillation, all-cause mortality, cardiovascular mortality, stroke, systemic arterial thromboembolism and unplanned hospitalizations for decompensated heart failure within 14 days after discharge from the index hospital stay.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: 18-80 years
  • Cardiac arrest due to acute myocardial infarction
  • Cardiac arrest ≤10 days ago
  • Left-ventricular ejecion fraction at hospital discharge: 36-50%
  • Sinus rhythm at hospital discharge
  • Optimal medical therapy

Exclusion criteria

  • Non-adult patients
  • Cardiac arrest due to another cause other than acute myocardial infarction
  • Philips ePatch® 2.0 not applicable
  • ICD or pacemaker indication
  • Known paroxysmal or persistent atrial fibrillation
  • Inability to comply with follow-up- Pregnancy

Trial design

100 participants in 1 patient group

Philips ePatch® 2.0
Description:
Patients who are discharged from the hospital with ECG patch (Philips ePatch® 2.0).
Treatment:
Device: ECG patch (Philips ePatch® 2.0)

Trial contacts and locations

0

Loading...

Central trial contact

Carsten Skurk, MD; Tharusan Thevathasan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems